Genetic and Pathological Testing Attitudes for Parkinson's Disease in At‐Risk Relatives
Abstract Background Parkinson's disease (PD) is increasingly recognized as a neurodegenerative disorder with a broad clinical spectrum and diverse biomarkers enabling early detection. α‐synuclein seed amplification assays (SAA) and genetic testing now allow identification of PD pathology in asymptomatic individuals.
Tal Weil +5 more
wiley +1 more source
Psychometric reliability of patient-reported visual analogue scales in subthalamic nucleus deep brain stimulation programming for Parkinson's disease. [PDF]
Off J +9 more
europepmc +1 more source
Reduced intracortical inhibition and enhanced intracortical facilitation in patients with functional tremor. [PDF]
Li J, Zhao J, Li Y, Jiao Y, Chen X.
europepmc +1 more source
A Vision-Based Algorithm for Assessing Head and Hand Tremor: Development and Validation Against IMU Sensors. [PDF]
Netukova S +5 more
europepmc +1 more source
Movement Disorders Clinical Practice, EarlyView.
Marjolein Muller, M. Fiorella Contarino
wiley +1 more source
Quantitative Assessment of Visible Nigrosome‐1 in Patients with Parkinson's Disease
Abstract Background The nigrosome‐1 (N1) sign on susceptibility‐weighted imaging (SWI) typically disappears in Parkinson's disease (PD), though some patients can show uni−/bilaterally preserved N1. Objective Investigating whether visible nigrosomes in PD patients differ from those of healthy subjects (HC). Methods Forty‐eight PD and 35 HC underwent 3 T‐
Maria Eugenia Caligiuri +10 more
wiley +1 more source
Objective tremor monitoring using tri-axis accelerometer in MRgFUS thalamotomy for essential tremor: a feasibility study. [PDF]
Liu KC +7 more
europepmc +1 more source
Severity‐Based and Family‐Centered Approaches to Deep Brain Stimulation in GNAO1‐Related Disorders
Movement Disorders Clinical Practice, EarlyView.
Jana Domínguez‐Carral +1 more
wiley +1 more source

